Weiming Xia

Research Associate Professor, Pharmacology & Experimental Therapeutics
Acting Associate Director of Research, Bedford Geriatric Research Education
Clinical Center, Bedford VA Medical Center



Dr. Xia completed his graduate studies at the University of Texas Medical School at Houston where he earned his MS and PhD degrees (Biochemistry and Molecular Biology). He completed his postdoctoral training in Alzheimer’s disease (AD) at Brigham and Women’s Hospital, Harvard Medical School. In 1999 he became Assistant Professor of Neurology at Harvard Medical School and established a NIH-funded research lab to study AD. In 2012 he joined Department of Veterans Affairs Bedford VA Medical Center, and he leads an independent lab to explore molecular mechanism and biomarkers for AD.

Research Interests

Dr. Xia’s research interests involve target identification, characterization, validation and early stage drug development, with exploration of clinical biomarkers for AD. He has established multiple platforms to quantify pathological proteins like amyloid β protein (Aβ), Tau, neuroinflammatory factors, and related biomarkers. He also develops Mass Spectrometry-based analytic approaches to explore biomarkers for AD and other central nervous system disorders.

ADC Role

Dr. Xia contributes basic and translational AD research for BU ADC, especially in quantitative and discovery biomarker studies using Mass Spectrometers.

For a full list of publications click here.

Profile Types

View all profiles